左主干病变合并与不合并糖尿病患者PCI与CABG的4项随机试验汇总分析
该研究汇总4项随机试验的个体患者数据,比较左主干病变患者中PCI与CABG的结局。共4393例患者,25.1%合并糖尿病。糖尿病与5年死亡和心血管事件更高相关;无论糖尿病状态,PCI与CABG的死亡风险无差异,PCI早期卒中更低但自发性心梗和再次血运重建更高,糖尿病患者晚期绝对超额风险更大。
要点
- 左主干病变患者中,糖尿病与5年死亡和心血管事件更高相关。
- 无论是否合并糖尿病,PCI与CABG的全因死亡风险无显著差异。
- PCI与CABG相比,早期卒中更低,但自发性心梗和再次血运重建更高,糖尿病者晚期绝对风险差更大。
核心结论
- 在左主干病变且被认为同样适合PCI或CABG的患者中,糖尿病与5年死亡和心血管事件更高相关。
- 与CABG相比,PCI无论糖尿病状态均不增加死亡风险且早期卒中更低,但自发性心梗和再次血运重建风险更高,糖尿病者晚期绝对超额风险更大。
研究设计与样本
- 汇总4项随机试验(SYNTAX、PRECOMBAT、NOBLE、EXCEL)的个体患者数据,纳入左主干病变且适合两种血运重建策略的患者。
- 共4393例患者,其中1104例(25.1%)合并糖尿病,按糖尿病状态分组,评估Kaplan-Meier事件率、Cox模型风险比及交互作用。
主要发现
- 糖尿病患者的5年死亡率为14.7%(158/1104),无糖尿病者为9.3%(297/3289),P<0.001。
- 糖尿病患者的自发性心梗率为6.7%(67/1104),无糖尿病者为3.7%(114/3289),P<0.001。
- 糖尿病患者的再次血运重建率为18.5%(189/1104),无糖尿病者为13.2%(410/3289),P<0.001。
- PCI与CABG的全因死亡风险在糖尿病患者中无差异(HR 1.11,95%CI 0.82-1.52),在无糖尿病患者中亦无差异(HR 1.08,95%CI 0.86-1.36;PintHR=0.87)。
- PCI与CABG相比,1年内卒中更低且无糖尿病状态异质性(PintHR=0.51);5年自发性心梗和再次血运重建在PCI后更高,无论糖尿病状态(交互P分别为0.47和0.18)。
关键数值与推荐
- 糖尿病患者PCI vs CABG的5年全因死亡:84/563(15.3%) vs 74/541(14.1%),HR 1.11(95%CI 0.82-1.52)。
- 无糖尿病患者PCI vs CABG的5年全因死亡:155/1634(9.7%) vs 142/1655(8.9%),HR 1.08(95%CI 0.86-1.36)。
- 糖尿病患者PCI vs CABG的5年自发性心梗:45/563(8.9%) vs 22/541(4.4%);无糖尿病:82/1634(5.3%) vs 32/1655(2.1%)。
- 糖尿病患者PCI vs CABG的5年再次血运重建:127/563(24.5%) vs 62/541(12.4%);无糖尿病:254/1634(16.3%) vs 156/1655(10.1%)。
- 1年后自发性心梗和再次血运重建的绝对风险差在糖尿病者中更大(4.9%和9.9%),无糖尿病者较小(2.1%和4.3%;PintARD分别为0.047和0.016)。
临床怎么用
- 对于左主干病变且同样适合PCI或CABG的患者,糖尿病状态不影响PCI与CABG在死亡风险上的等效性,但PCI早期卒中更低。
- 选择PCI时需告知患者自发性心梗和再次血运重建风险更高,尤其合并糖尿病者晚期绝对风险差更大。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The aim of this study was to investigate outcomes in patients with left main disease with and without diabetes randomized to PCI versus CABG. METHODS: Individual patient data were pooled from 4 trials (SYNTAX [Synergy Between PCI With Taxus and Cardiac Surgery], PRECOMBAT [Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease], NOBLE [Nordic-Baltic-British Left Main Revascularisation Study], and EXCEL [Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization]) that randomized patients with left main disease to PCI or CABG. Patients were considered suitable for either approach. Patients were categorized by diabetes status. Kaplan-Meier event rates, Cox model hazard ratios, and interactions were assessed. RESULTS: Among 4393 patients, 1104 (25.1%) had diabetes. Patients with diabetes experienced higher rates of 5-year death (158/1104 [Kaplan-Meier rate, 14.7%] versus 297/3289 [9.3%]; P<0.001), spontaneous myocardial infarction (MI; 67/1104 [6.7%] versus 114/3289 [3.7%]; P<0.001), and repeat revascularization (189/1104 [18.5%] versus 410/3289 [13.2%]; P<0.001). Rates of all-cause mortality did not differ after PCI versus CABG in those with (84/563 [15.3%] versus 74/541 [14.1%]; hazard ratio, 1.11 [95% CI, 0.82-1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86-1.36; PintHR=0.87) diabetes. Rates of stroke within 1 year were lower with PCI versus CABG in the entire population, with no heterogeneity based on diabetes status (PintHR=0.51). The 5-year rates of spontaneous MI and repeat coronary revascularization were higher after PCI regardless of diabetes status (spontaneous MI: 45/563 [8.9%] versus 22/541 [4.4%] in diabetes and 82/1634 [5.3%] versus 32/1655 [2.1%] in no diabetes, PintHR=0.47; repeat revascularization: 127/563 [24.5%] versus 62/541 [12.4%] in diabetes and 254/1634 [16.3%] versus 156/1655 [10.1%] in no diabetes, PintHR=0.18). For spontaneous MI and repeat revascularization, there were greater absolute risk differences beyond 1 year in patients with diabetes (4.9% and 9.9%) compared with those without (2.1% and 4.3%; PintARD=0.047 and 0.016). CONCLUSIONS: In patients with left main disease considered equally suitable for PCI or CABG and with largely low to intermediate SYNTAX scores, diabetes was associated with higher rates of death and cardiovascular events through 5 years. Compared with CABG, PCI resulted in no difference in the risk of death and a lower risk of early stroke regardless of diabetes status, and a higher risk of spontaneous MI and repeat coronary revascularization, with larger late absolute excess risks in patients with diabetes. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT01205776, NCT0146651, NCT00422968, and NCT00114972.
引用
- Gaba P, Sabik JF, Murphy SA, et al. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials. Circulation. 2024. PMID: 38465592. doi:10.1161/CIRCULATIONAHA.123.065571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。